OTC:DFPH | Cash Flow Statement | Starling Oncology, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$9.79M
2026-03-31-$2.49M$1.62M-$2.22M$1.04M-$1.04M-$28,000.00
2025-12-31-$7.51M$1.63M$3.23M$1.06M-$1.06M$3.73M
2025-09-30-$16.5M
2025-06-30-$17.01M
2025-03-31-$19.59M$1.78M-$4.99M$328,000.00-$202,000.00-$4.74M
2024-12-31-$13.18M$1.71M$4.19M$1.76M-$1.76M$0.00-$164,000.00
2024-09-30-$16.11M
2024-06-30-$15.48M
2024-03-31-$19.89M$1.49M-$15.88M$610,000.00$19.39M-$938,000.00
2023-12-31-$18.75M$1.58M-$3.89M$861,000.00$11.63M$0.00-$1.78M
2023-09-30-$17.42M
2023-06-30-$16.9M
2023-03-31-$30M$1.27M-$15.45M$1.84M$18.4M-$1.71M
2022-12-31-$11.01M$1.19M-$14M$2M-$32.57M$0.00-$847,000.00
2022-09-30-$2.67M
2022-06-30-$5.45M$9M
2022-03-31$19.29M$987,000.00-$16.98M$1M-$1M-$1.66M
2021-12-31-$10.16M$920,000.00-$23.34M$871,000.00-$9.15M$0.00$136.13M
2021-09-30-$2.98M
2021-06-30$3.21M
2021-03-31-$996,000.00$777,000.00$464,000.00$619,000.00-$1.45M$22.4M
2020-12-31-$8.51M$1.01M$221.16M-$219.59M
2020-09-30-$2.42M
2020-06-30-$2.62M
2020-03-31-$776,839.00-$28,750.00-$230M$231.51M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$60.61M$6.94M-$24.59M$3.2M-$3.07M$11.56M
2024-12-31-$64.66M$6.29M-$26.54M$3.79M$46.21M$0.00-$3.49M
2023-12-31-$83.07M$5.87M-$36.32M$4.57M$62.64M$1.02M-$6.85M
2022-12-31$152,000.00$4.41M-$61.76M$5.53M-$131.61M$9M$92.21M
2021-12-31-$10.93M$3.34M-$32.68M$2.85M-$12.15M$0.00$154.01M
2020-12-31-$14.32M$3.18M$508,000.00$1.19M-$8.84M$11.89M